Gongwin Biopharm Holdings Co., Ltd. (TPEX: 6617)
Health Care · Biotechnology · TW
NT$126.50
+6.30% today · +32.5% 1Y
Gongwin Biopharm Holdings Co., Ltd. (TPEX: 6617) operates in the Biotechnology industry within the Health Care sector. The company is valued at $472.24M and employs 20 people.
Over the last twelve months the share price has gained 32.5%, trading between 58.30 and 149.00.
Tweenvest scores Gongwin Biopharm Holdings Co., Ltd. across four factors: quality 47/100, value 37/100, growth 100/100. Its strongest factor is growth.
6617 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $472.24M
- Revenue (TTM)
- $1.33M
- P/E
- —
- EPS
- -1.35
- Dividend yield
- —
- Beta (5Y)
- 0.31
- 52-week high
- NT$149.00
- 52-week low
- NT$58.30
- Avg volume (3M)
- —
- Shares outstanding
- 121.12M
- Employees
- 20
- Next earnings
- —
About Gongwin Biopharm Holdings Co., Ltd.
Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the development of oncology therapeutics. The company's robust pipeline features several drug candidates, including PTS302, which has successfully concluded Phase III clinical trials for lung cancer. Additionally, PTS100 is currently progressing through Phase II clinical trials for liver cancer, while PTS-02 is being developed to address adenoid cystic carcinoma, and PTS500 targets malignant pleural effusion. Established in 2014, Gongwin Biopharm is headquartered in Taipei, Taiwan.
- ISIN
- KYG409471060
- Founded
- 2014
- Listed since
- Feb 8, 2017
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Steminent Biotherapeutics Inc.TPEX: 7729 | $479.33M | NT$193.00 | +0.78% |
| Thalys Medical Technology Group CorporationSHSE: 603716 | $477.36M | CN¥14.40 | -12.57% |
| Onconic Therapeutics Inc.KOSDAQ: A476060 | $473.42M | ₩13,900.00 | -6.52% |
| Genfit S.A.ENXTPA: GNFT | $472.79M | €8.40 | +1.45% |
| Neurogene Inc.NasdaqGM: NGNE | $471.27M | $23.55 | -3.01% |
| Beijing Leadman Biochemistry Co.,Ltd.SZSE: 300289 | $469.93M | CN¥5.78 | -5.56% |
| Qingdao Vland Biotech INC.SHSE: 603739 | $468.53M | CN¥12.39 | -10.48% |
| Lifecome Biochemistry Co.,Ltd.SZSE: 002868 | $467.33M | CN¥20.12 | -8.96% |
Figures last refreshed Oct 18, 2026.